Physician profile
Edward Williams
NPI 1306831623
$1,191.77
in general payments reported to CMS, 2019-2025
17 companies · $16.83 in 2025
The $16.83 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $149 · 2021: $86.15 · 2022: $42.27 · 2023: $303 · 2024: $29.88 · 2025: $16.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $250.76 | 2019-2023 | Xarelto |
| Pfizer INC. | $188.17 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $141.72 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $140.84 | 2021-2023 | Verquvo |
| Amgen INC. | $139.90 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $80.11 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.12 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $56.44 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $16.83 | 2025 | General - Therapies |
| Astellas Pharma US INC | $15.95 | 2019 | |
| Abbott Laboratories | $15.88 | 2023 | Aveir |
| Kiniksa Pharmaceuticals International, Plc | $14.88 | 2024 | Arcalyst |
| Novo Nordisk INC | $14.80 | 2023 | Ozempic, Rybelsus |
| Arbor Pharmaceuticals, INC. | $13.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.07 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.81 | 2019 | |
| Allergan, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.